These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 38322311)

  • 21. Mucormycosis of the Spine: A Case Report and Review of the Literature.
    Patel J; Pennington Z; Hersh AM; Hung B; Scuibba DM; Lo SL
    Cureus; 2022 Mar; 14(3):e23623. PubMed ID: 35494962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
    Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
    Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B.
    Safi M; Ang MJ; Patel P; Silkiss RZ
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100771. PubMed ID: 32551404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections.
    Lakhani P; Patil A; Majumdar S
    J Ocul Pharmacol Ther; 2019; 35(1):6-22. PubMed ID: 30481082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.
    Jeong W; Keighley C; Wolfe R; Lee WL; Slavin MA; Kong DCM; Chen SC
    Clin Microbiol Infect; 2019 Jan; 25(1):26-34. PubMed ID: 30036666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nosocomial Rhinocerebral Mucormycosis: Two Cases with a Temporal Relationship.
    Sánchez-Gil J; Guirao-Arrabal E; Parra-García GD; Luzón-García MDP; Fe Bautista-Marín M; Barayobre-Barayobre M; Fontalba-Navas A
    Mycopathologia; 2017 Oct; 182(9-10):933-935. PubMed ID: 28639065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraorbital Irrigation of Amphotericin B in the Treatment of Rhino-Orbital Mucormycosis.
    Joos ZP; Patel BC
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):e13-e16. PubMed ID: 25794024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival.
    Vironneau P; Kania R; Morizot G; Elie C; Garcia-Hermoso D; Herman P; Lortholary O; Lanternier F;
    Clin Microbiol Infect; 2014 May; 20(5):O336-9. PubMed ID: 24118291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healthcare-associated mucormycosis.
    Rammaert B; Lanternier F; Zahar JR; Dannaoui E; Bougnoux ME; Lecuit M; Lortholary O
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S44-54. PubMed ID: 22247444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common fungus, an unusual (and deadly) infection.
    Tan S; Aronowitz P
    Am J Med; 2011 Nov; 124(11):1023-4. PubMed ID: 22017779
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis.
    Mahdy RA; Nada WM; Wageh MM; Kader MA; Saleh MM; Alswad MM
    Cutan Ocul Toxicol; 2010 Sep; 29(3):193-7. PubMed ID: 20462395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.
    Pelton RW; Peterson EA; Patel BC; Davis K
    Ophthalmic Plast Reconstr Surg; 2001 Jan; 17(1):62-6. PubMed ID: 11206749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of local amphotericin B therapy for sino-orbital fungal infections.
    Seiff SR; Choo PH; Carter SR
    Ophthalmic Plast Reconstr Surg; 1999 Jan; 15(1):28-31. PubMed ID: 9949426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.
    Luna JD; Ponssa XS; Rodríguez SD; Luna NC; Juárez CP
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):706-8. PubMed ID: 8858637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucormycosis.
    Fleckner RA; Goldstein JH
    Br J Ophthalmol; 1969 Aug; 53(8):542-8. PubMed ID: 5811223
    [No Abstract]   [Full Text] [Related]  

  • 36. Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report.
    Zhou Y
    Case Rep Ophthalmol; 2024; 15(1):122-128. PubMed ID: 38322311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
    Nair AG; Dave TV
    Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis-has anything changed in the past 20 years?
    Vaughan C; Bartolo A; Vallabh N; Leong SC
    Clin Otolaryngol; 2018 Dec; 43(6):1454-1464. PubMed ID: 29947167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
    Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
    Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.